New Delhi: After Pfizer Inc and BioNTech announced successful interim data earlier on Monday, the work to distribute the experimental COVID-19 vaccine developed by the biotech companies is gearing up. However, it will not be available in the local pharmacies for the general public any time soon. The data, which sent U.S. stocks to record highs, showed that the two companies’ experimental vaccine is 90% effective at preventing COVID-19. While data on safety is still…